Revisiting Freund's incomplete adjuvant for vaccines in the developing world
- 1 September 2005
- journal article
- review article
- Published by Elsevier in Trends in Parasitology
- Vol. 21 (9), 412-414
- https://doi.org/10.1016/j.pt.2005.07.005
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum MalariaInfection and Immunity, 2005
- Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trialThe Lancet, 2004
- Biochemical and Immunological Characterization of Bacterially Expressed and RefoldedPlasmodium falciparum42-Kilodalton C-Terminal Merozoite Surface Protein 1Infection and Immunity, 2003
- A New MF59-Adjuvanted Influenza Vaccine Enhances the Immune Response in the Elderly with Chronic Diseases: Results from an Immunogenicity Meta-AnalysisGerontology, 2003
- Vaccination of Monkeys with RecombinantPlasmodium falciparumApical Membrane Antigen 1 Confers Protection against Blood-Stage MalariaInfection and Immunity, 2002
- Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccinesExpert Review of Vaccines, 2002
- Perspective: Hypothesis: Serum IgG Antibody Is Sufficient to Confer Protection against Infectious Diseases by Inactivating the InoculumThe Journal of Infectious Diseases, 1995
- LONG-TERM MORTALITY FOLLOW-UP OF ARMYRECRUITS WHO RECEIVED ADJUVANT INFLUENZA VIRUS VACCINE IN 1951–19531American Journal of Epidemiology, 1972
- A Cell Culture Assay to Evaluate the Toxicity of Arlacel AExperimental Biology and Medicine, 1970
- Influence of Antigens on Release of Free Fatty Acids from Arlacel A (Mannide Monooleate)Experimental Biology and Medicine, 1966